Insilico Study of Type II Diabetes and Effective Drugs: a Bioinformatics Study of Diabetes Genes - Satyavani Guttula - Books - LAP LAMBERT Academic Publishing - 9783848483204 - July 24, 2012
In case cover and title do not match, the title is correct

Insilico Study of Type II Diabetes and Effective Drugs: a Bioinformatics Study of Diabetes Genes


Get an email once the item is available
Do you have a profile? Log in
Get notified about new Satyavani Guttula releases
Add to your iMusic wish list

Not rated yet

Diabetes is an important and increasingly common global health problem. The World Health Organization has estimated that about 170 million people currently have diabetes worldwide. Environmental factors such as obesity, a diet high in sugar, and a sedentary lifestyle are all risk factors for developing Type 2 diabetes. This book provides the basic knowledge to analyze Microarray data of diebetes. Clustering is done to the genes which are more expressed in Type II diabetes. Phylogenetic analysis is done on the basis of the sequence similarity by which the rate of expression is also similar. Two proteins Beliverdine and Uroporphyrinogen are taken and eight antidiabetic drugs such as Acarbose, Gliquidone, Metformin, Miglitol, Mitiglinide, Pioglitazone, Sitagliptin, Voglibose. These drugs are used as ligands. The two receptors are subjected to docking with eight ligands. ACARBOSE is determined as most efficient drug.

Media Books     Paperback Book   (Book with soft cover and glued back)
Released July 24, 2012
ISBN13 9783848483204
Publishers LAP LAMBERT Academic Publishing
Pages 128
Dimensions 150 × 220 × 10 mm   ·   199 g
Language English